Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-07-30

Clinical Trial Update: Study on Cannabinoid Receptor Expression in Gastrointestinal Diseases

View source ↗

Summary

A completed clinical trial examined cannabinoid receptor expression in gastrointestinal diseases. The study covered ulcerative colitis, Crohn's disease, and col…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Medical University of Graz | Conditions: Ulcerative Colitis, Crohn's Disease | Status: COMPLETED